1. Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes;Rawshani;N. Engl. J. Med.,2017
2. Glycemic Control and Excess Mortality in Type 1 Diabetes;Lind;N. Engl. J. Med.,2014
3. Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R.A., Antunes, M.J., Christodorescu, R.M., Crawford, C., Di Angelantonio, E., and Eliasson, B. (Eur. Heart J., 2023). 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC), Eur. Heart J., online ahead of print.
4. Angiogenin-new important parameter in the assessment of ischaemic heart disease?;Siebert;Kardiol. Pol.,2006
5. Inhibition of degranulation of polymorphonuclear leukocytes by angiogenin and its tryptic fragment;Tschesche;J. Biol. Chem.,1994